Trial intelligence / Profile preview

Piritrexim in Advanced Urothelial Carcinoma

NCT00002914Phase 2Completed

Sponsor
Eastern Cooperative Oncology Group
Start
Jul 1997
Primary completion
Jun 2001
Modality
Small Molecules
Countries
2
01

Overview

A Phase 2 trial of piritrexim in urothelial carcinoma (UC), sponsored by Eastern Cooperative Oncology Group. Started Jul 1997; status: completed.

02

Drugs

piritrexim
03

Conditions

urothelial carcinoma (UC)

Beyond the preview

Go deeper on NCT00002914.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00002914.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call